X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.indianpharmapost.com/drug-approval/aurobindo-pharma-receives-usfda-approval-for-mometasone-furoate-monohydrate-nasal-spray-15417
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217460
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-25-2023-68767.pdf
https://www.ema.europa.eu/en/documents/overview/atectura-breezhaler-epar-medicine-overview_en.pdf
https://www.expresspharma.in/health-canada-approves-ryaltris-for-treatment-of-seasonal-allergic-rhinitis/
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-bets-on-respiratory-drug-licensing-deals-to-improve-business/articleshow/94232059.cms
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmarks-partner-hikma-launches-specialty-drug-ryaltris-in-us/articleshow/93884151.cms
https://www.prnewswire.com/news-releases/hikma-launches-ryaltris-seasonal-allergic-rhinitis-nasal-spray-in-the-us-301614600.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-13-2022-1657691440.pdf
https://health.economictimes.indiatimes.com/news/pharma/glenmark-launches-fdc-asthma-medication-in-india/92247274
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-14-2021-1618506639.pdf
https://www.novartis.com/news/media-releases/novartis-phase-iii-iridium-data-lancet-respiratory-medicine-show-benefit-enerzair-breezhaler-qvm149-first-class-inhaled-labalamaics-combination-uncontrolled
https://www.ema.europa.eu/en/documents/assessment-report/bemrist-breezhaler-epar-public-assessment-report_en.pdf
http://www.pmlive.com/pharma_news/novartis_asthma_triple_heads_chmps_latest_meeting_1339751
https://www.ema.europa.eu/en/news/first-triple-combination-therapy-asthma-optional-electronic-sensor
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-23-26-march-2020
https://www.prnewswire.com/news-releases/hikma-and-glenmark-pharmaceuticals-enter-into-exclusive-licensing-agreement-for-commercialising-ryaltris-seasonal-allergic-rhinitis-nasal-spray-in-the-us-301012213.html
https://www.business-standard.com/article/pti-stories/glenmark-gets-approval-from-australian-regulator-to-commercialise-ryaltris-119122000275_1.html
https://endpts.com/with-ema-review-in-progress-novartis-unveils-more-positive-data-on-asthma-therapy/
https://www.prnewswire.com/news-releases/sosei-heptares-notes-the-announcement-of-positive-results-from-phase-iii-iridium-study-of-inhaled-combination-qvm149-in-patients-with-uncontrolled-asthma-300927777.html
https://www.fiercepharma.com/pharma-asia/fiercepharmaasia-hifibio-s-kite-backed-c-round-kyowa-kirin-s-parkinson-s-nod-relief-for
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-14-2019-1565765849.pdf
https://www.fiercepharma.com/manufacturing/glenmark-respiratory-drug-has-wind-knocked-out-it-by-fda-questions-production
http://www.pharmatimes.com/news/novartishits_targets_in_late-stage_qmf149_asthma_trial_1289540
http://www.pharmafile.com/news/522692/investigational-novartis-therapy-smashes-primary-and-secondary-endpoints-uncontrolled-as
https://www.biospectrumindia.com/news/57/12745/glenmark-pharma-signs-an-agreement-with-grandpharma-.html
http://www.glenmarkpharma.com/sites/default/files/Glenmark-Pharma-enters-into-an-Exclusive-Licensing-Agreement-with-Yuhan-Corporation-for-commercializing-Investigational-Seasonal-Allergic-Rhinitis-Nasal-Spray-Ryaltris.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207899
https://www.thehindubusinessline.com/companies/glenmarkpharma-arm-inks-pact-with-seqirus/article24354471.ece
https://www.prnewswire.com/news-releases/glenmark-pharmaceuticals-announces-the-companys-first-new-drug-application-for-ryaltris-for-patients-with-seasonal-allergic-rhinitis-300651988.html
http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2018/02/news_detail_002907.jsp&mid=WC0b01ac058004d5c1
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-7-2018-1517980699.pdf
https://www.gov.uk/government/news/successful-reclassification-of-nasonex-allergy-control-nasal-spray
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207989
http://www.fiercepharmamarketing.com/story/allergy-battle-goes-young-gsks-flonase-sanofis-nasacort-roll-out-kid-labele/2016-04-04
https://www.pharmacompass.com/pdf/news/apotex-incs-generic-mometasone-furoate-approved-in-us-as-a-glucocorticosteroid-1459160291.pdf
http://www.fiercepharma.com/story/advera-health-novartis-gsk-asthma-meds-linked-more-side-effects-merck-drugs/2015-11-18
http://www.prnewswire.com/news-releases/despite-generic-erosion-of-current-market-leaders-the-asthma-market-will-remain-steady-over-the-next-decade-largely-owing-to-the-forecasted-launch-of-a-new-class-of-therapy-300147049.html
http://www.fiercepharma.com/story/merck-job-cutting-tensions-displayed-public-emails-frazier-union-rep/2015-08-19
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2015/54118r-eng.php
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2015/43927a-eng.php
Market Place
Share 
